Clarification1 Jun 2026, 02:39 pm
Dabur Clarifies on USFDA Data Integrity Observations
AI Summary
Dabur India Ltd clarified a news item regarding USFDA observations at its manufacturing plant in Silvassa, Dadra & Nagar Haveli. The company stated that the observations concern a small part of their operations, generating insignificant revenue. Dabur is actively engaged with the USFDA and has shared a corrective action plan. The company reiterates its commitment to quality, safety, and compliance, stating there is no impact on financials or operations.
Key Highlights
- USFDA flagged data integrity and maintenance lapses at a Dabur India plant.
- The plant in question contributes insignificantly to Dabur's revenue.
- Dabur is working with the USFDA to resolve the concerns raised.
- The company maintains strong controls to ensure quality systems are not compromised.
- Dabur states there is no impact on the company's financials or operations.
Price Impact
More from DABUR